PMI — Picard Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $703.71m
- $745.25m
- $4.39m
Annual cashflow statement for Picard Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -11.2 | -15.6 | -21.1 |
| Depreciation | |||
| Non-Cash Items | 1.83 | 1.07 | 7.67 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -1.93 | 3.28 | 0.963 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Cash from Operating Activities | -10.7 | -10.6 | -11.9 |
| Capital Expenditures | -0.029 | -0.007 | 0 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -0.008 | -0.002 | 0 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -0.037 | -0.009 | 0 |
| Financing Cash Flow Items | 0 | 2.65 | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 5.52 | 10.8 | 11.7 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -5.1 | 0.092 | -0.148 |